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Vmax as the dependent variable, found no correlations betweenInsulin-dependent diabetic sibling pairs are concordant for
any of the subjects’ clinical and demographic variables.sodium-hydrogen antiport activity.
Conclusions. Familial concordance for Na1/H1 antiport ac-Background. Recent findings of enhanced Na1/H1 antiport
tivity in long-term cultured skin fibroblasts from type 1 diabeticactivity in cultured fibroblasts and immortalized lymphoblasts
siblings suggests that at least some of the in vitro phenotypicalfrom type 1 diabetic patients with nephropathy support the
characteristics of these cells are likely to be genetically deter-view that a phenotypic or genotypic factor(s) underlies ne-
mined and to be, at least in part, independent of in vivo meta-phropathy risk. This study evaluated the kinetic properties of
bolic control.Na1/H1 antiporter in cultured fibroblasts from families with
two siblings affected by type 1 (insulin-dependent) diabetes.
Methods. Seventeen diabetic sibling pairs were studied. The
age was 38 6 10 years (mean 6 sd) in probands, the first to The epidemiological evidence that only a subset of
develop diabetes, and 39 6 7 in siblings; the duration of diabetes diabetic patients is susceptible to renal damage [1, 2]was, by definition, longer in probands (24 6 12 vs. 17 6 8 years
and the demonstration of clear familiar clustering ofin siblings). Na1/H1 antiport activity was determined using a
diabetic nephropathy [3, 4] are consistent with the possi-microfluorometric technique with the pH sensitive dye 29,79-
bis(2-carboxyethyl)-5(6)-carboxyfluorescein in skin fibroblasts bility that genetic factors may partially explain the risk
cultured for at least six passages. of or protection from diabetic renal disease. Predisposi-
Results. There were no significant differences between pro- tion to hypertension and cardiovascular disease may be
bands and siblings for the following parameters: glycated hemo-
important determinants of susceptibility to renal compli-globin, 8.3 6 0.8% in probands and 8.6 6 1.4% in siblings;
cations of diabetes because raised blood pressure (BP)creatinine clearance, 103 6 24 ml/min/1.73 m2 in probands and
[5] and cardiovascular disease [6] are more prevalent103 6 25 in siblings; albumin excretion rate, 6.8 (1 to 860) mg/
min (median and range) in probands and 4.9 (2 to 1334) in in nondiabetic parents of type I diabetic patients with
siblings. Intracellular pH and buffering capacity were superim- nephropathy.
posable in the sibling pairs. The Vmax for the antiport was 39.2 6 These observations have raised interest in the search14.7 mmol/liter cell/min in probands and 40.3 6 17.6 in siblings.
for intermediate phenotypes, which are significantly as-The internal pH for half-maximal activation (Km) and Hill
sociated with diabetic nephropathy. Such intermediatecoefficient was also similar in probands and siblings. There
were correlations between probands and siblings in values for phenotypes could be useful for early definition of risk
intracellular pH (r 5 0.51, P , 0.04), Vmax (r 5 0.84, P , and might help clarify the molecular mechanisms leading
0.0001), and buffering capacity (r 5 0.53, P , 0.03). Glycated to diabetic nephropathy. Elevated Na1/H1 antiporter ac-
hemoglobin values over five years were not significantly corre- tivity has been associated with diabetic renal disease inlated in the sibling pairs (r 5 0.3, P . 0.1). Vmax was related
both type I and type II diabetic patients [7–13]. The Na1/with the albumin excretion rate (r 5 10.49, P 5 0.005) and
H1 antiporter is a membrane transport system found inglycated hemoglobin (r 5 10.41, P 5 0.017) in the total cohort
of sibling pairs. However, multiple regression analysis, using all eukaryotic cells. Exchanging intracellular protons for
extracellular sodium, the antiporter plays a central role
in three major cellular events: (a) intracellular pH (pHi)
1 See Editorial by Giancarlo Viberti, p. 2526. regulation, (b) cell volume control, and (c) stimulus-
response coupling and cell proliferation [14]. This trans-Key words: sodium-hydrogen exchange, type 1 diabetes, diabetic ne-
phropathy, skin fibroblasts, albumin excretion rate, sibling pairs. port system also plays an important role in renal sodium
reabsorption. There are at least five different isoformsReceived for publication July 7, 1998
of Na1/H1 antiport. The first, referred to as NHE-1, isand in revised form January 21, 1999
Accepted for publication January 25, 1999 expressed in most cell types, is sensitive to amiloride,
and is activated by growth factors [14]. 1999 by the International Society of Nephrology
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Kinetic analyses of Na1/H1 antiporter activity in long- ance (CCr) using these urine collections was used to esti-
mate the glomerular filtration rate (normal range, 90 toterm cultured cells from type I diabetic patients with
nephropathy demonstrated that maximal velocity was 130 ml/min/1.73 m2). Plasma and urine creatinine concen-
trations were measured using a modification of the Jaffe´increased when compared with cells from normoalbumi-
nuric patients and nondiabetic control subjects [7, 8, 12]. reaction. Arterial BP was measured on multiple occa-
sions by trained CRC nursing staff with a standard mer-The presence of this enhanced activity in cells from dia-
betic nephropathy patients is consistent with genetic con- cury sphygmomanometer, and mean values are pre-
sented. Hypertension was defined as systolic BP of 140trol of this phenotype. However, influences of advanced
renal damage or glycemic control on cellular Na1/H1 mm Hg or more or diastolic BP of 90 mm Hg or more
or known treatment for hypertension. Hemoglobin A1cantiporter activity could not be excluded by these studies.
Type I diabetic siblings offer a unique human model (HbA1c) was measured by high-performance liquid chro-
matography (HPLC) in a single laboratory (normal val-for the exploration of the relationship between renal
status, metabolic control, and in vitro Na1/H1 antiporter ues, 4.0 to 6.5%). The mean of prospective multiple
values for each patient over a five-year longitudinal studyactivity. This study evaluated whether cultured skin fi-
broblasts from type I diabetic sibling pairs share common period was used (median, six measurements per patient,
range 2 to 16).phenotypic characteristics of in vitro Na1/H1 antiporter
activity.
Cell culture
Skin biopsy was done under local anesthesia with a
METHODS
3 mm punch at the time of kidney biopsy and at the
Patients already-anesthetized percutaneous kidney biopsy site.
The biopsy material was cut into 1 mm3 fragments andPatients were recruited from a registry of type I dia-
betic patients in the United States Midwest that was transferred to a 25 cm2 cell culture flask. Fibroblasts
were cultured in Dulbecco’s modified Eagle’s mediummaintained by one of the authors (J. Barbosa). Adult
type I diabetic patients with one or more type I diabetic (DMEM) containing 5 mm glucose supplemented with
10% fetal calf serum (FCS). After the fourth passage,siblings were eligible for study. All siblings with a diabe-
tes duration of at least 10 years were asked to participate, cells were harvested and stored in liquid nitrogen. Frozen
cells were transported on dry ice from the University ofwith the exception of one family, in which siblings with
a diabetes duration of six and five years, respectively, Minnesota to the University of Padova for characteriza-
tion of Na1/H1 antiport activity. For each experiment,were recruited. The proband was the first patient to
develop diabetes; the second was the sibling. All willing fibroblasts were then thawed and grown as described
earlier here. All experiments were performed betweensibling pairs meeting these criteria were accepted with-
out any exclusion for the presence or absence of long- the 6th and 10th passages.
term diabetic complications. However, neither sibling
Measurement of intracellular pH and Na1/H1could have advanced renal disease (serum creatinine of
antiport activitymore than 2.0 mg/dl). Twenty-one eligible sibling pairs
provided informed consent for this study, which was After thawing, cells were seeded onto cover slips using
approximately 2 to 3 3 105 cells per cover slip. Measure-approved by the Committee on the Use of Human Sub-
jects in Research at the University of Minnesota. Seven- ments were made after a growth period of at least 36
hours in DMEM and after achievement of morphologicteen of these 21 pairs had successful skin fibroblast cul-
tures established and are the subject of this report. These confluence. That the cells were in the plateau phase of
growth, in which there is a steady-state condition withpatients are the subjects of a five-year prospective study.
A group of 12 normal subjects without a family history an almost completely ceased cell proliferation, was con-
firmed by evaluation of [3H]-thymidine incorporation inof hypertension and cardiovascular disease served as
controls. fibroblasts grown in the same conditions. At confluence,
[3H]-thymidine incorporation in fibroblasts was 10 to 15
Study protocol times lower than that observed in cells during the log
phase of growth and similar to those observed in fibro-Patients were admitted to the Clinical Research Cen-
ter (CRC) at the University of Minnesota for three days blasts cultured in serum-free medium (data not shown).
All experiments were in duplicate and were all per-of testing. Three carefully timed (12 hr) urine samples
were collected for the measurement of albumin excretion formed by an operator masked to the identity of the
subjects studied. pHi was measured using the pH-sensi-rate (AER) by fluorescent immunoassay (normal values,
less than 15 mg/min). Values of 20 to 200 mg/min were tive dye 29,79-bis(2-carboxyethyl)-5(6)-carboxyfluorescein
(BCECF)/acetoxymethylester (AM) as previously de-defined as microalbuminuria, and values of more than
200 mg/min were defined as proteinuria. Creatinine clear- scribed [13, 15]. Briefly, fibroblasts on cover slips loaded
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with BCECF-AM (10 mmol/liter in DMEM without se- the Henderson-Hasselbach equation using a pKa for
NH3 of 8.89, and (b) the formula D[NH4]i/DpHi, as de-rum) at 378C for 20 minutes were inserted into a specially
constructed thermostatic cuvette in a Perkin-Elmer LS-50 scribed [17]. Intracellular buffering capacity (mmol/liter/
pH unit) was multiplied by change in intracellular pHLuminescence Spectrometer (Perkin-Elmer Corp., Ana-
lytical Instruments, Norwalk, CT, USA). The two excita- in order to convert rates of intracellular alkalization (in
pH units/min) to H1 equivalent efflux rates (in mmol/tion wavelengths were set at 490 and 435 nm (slit widths
5 nm) with emission at 530 nm (slit widths 5 nm). Au- liter/min).
All chemicals were obtained from Sigma Chemicaltofluorescence was subtracted from fluorescence read-
ings before the calculation of 490/435 ratios. Co. (St. Louis, MO, USA), except for BCECF-AM,
which was purchased from Calbiochem Co. (La Jolla,Intracellular pH in fibroblasts was determined in the
HEPES-buffered saline (140 mm NaCl, 5 KCl, 2 mm CA, USA).
CaCl2, 1 mm MgSO4, 5 mm glucose, 20 mm HEPES/Tris,
Statistical analyses1 g/liter bovine serum albumin, pH 7.4). The 490/435
ratios were subsequently converted to pH values at the Statistical calculations were performed with Statistical
Package for the Social Sciences (SPSS-PC). AER values,end of each experiment by construction of a calibration
curve to prevent bias from potential differences in the not normally distributed, are presented as median and
range and were logarithmically transformed prior to sta-position of the cover slip. This calibration of the fluores-
cent signal was achieved, as previously described, using tistical analysis.
The Hill equation was used to model the Na1/H1 anti-high-concentration K1 buffers of various pH values con-
taining 7 mmol/liter of nigericin [16]. port kinetics [18], to obtain values for estimated maxi-
mum rate from pHi activation curve (Vmax), the pHi forAfter the determination of intracellular pH in fibro-
blasts, cells were clamped at different intracellular pH half-maximal activation (pH0.5), and the apparent Hill
coefficient for the internal H1 binding sites of the anti-(6.0, 6.2, 6.4, 6.6, 6.8, and 7.0; a single cover slip per each
different acid loading) using a KCl buffer with nigericin port. A Hill coefficient of more than one indicates posi-
tive cooperativity for H1binding. The computer program(7 mmol/liter) [9]. When this acid-loading procedure was
completed, nigericin was removed by incubation for five used to derived these kinetic parameters was a recursive
nonlinear least squares algorithm (P-fit; Biosoft Corpo-minutes in a Na1-free buffer (135 mm choline chloride,
2 mm CaCl2, 1 mm MgCl2, 5 mm glucose, 20 mm HEPES/ ration, Cambridge, UK). Calculated sem was in the range
of 5 to 10% for Vmax and less than 4.0 for pH0.5 and HillTris, pH 7.4) containing 1 g/liter defatted albumin. The
absence of any intracellular pH recovery over a period of coefficient.
Data are presented as mean 6 sd unless otherwisefive minutes demonstrated that the cells cannot regulate
their pH in the absence of external Na1. stated. Comparisons between type I diabetic siblings
were done by paired t-test. Correlations of values amongThe cells were then exposed again to the HEPES-
buffered saline (Na15 140 mmol/liter, pH 7.4) to activate sibling pairs were done by linear regression analysis.
One-way analysis of variance was performed to examinethe Na1/H1 exchange. Upon addition of this sodium-rich
medium, intracellular pH increased linearly with time the influence of sibship on renal functional parameters
and kinetic parameters of Na1/H1 exchange. This wasfor at least 20 seconds. The same experiment of acid
loading to different pH and studying external Na1-depen- done by comparing the variance between siblings to the
variance among all patients for each variable. Simpledent H1 efflux was repeated in the presence of 1 mm
amiloride, an inhibitor of Na1/H1 antiport activity in or- linear regression and multiple regression analyses were
performed to determine if age, duration of diabetes, gen-der to determine the exchange caused by the antiport.
The rate of change in intracellular pH caused by Na1/ der, AER, or HbA1c were related to the measured kinetic
parameters of Na1/H1 antiport activity. A two-tailed PH1 antiport was considered the difference between the
slope of the initial rate of alkalization in HEPES-buf- value of less than 0.05 was considered significant.
fered saline and that measured in the presence of amilor-
ide. All slopes had correlation coefficients exceeding 0.96
RESULTS
and were obtained from 40 readings at 0.5-second inter-
Clinical features and renal functionvals taken over 20 seconds from the addition of the
solutions. Probands and siblings were similar in age, gender,
and body mass index (BMI; Table 1). The 12 controlsCells were reclamped at the same intracellular pH and
exposed to 10 mm ammonium chloride as previously (7 males) were similar in age (37 6 6 years) and BMI
(24.5 6 2.1 kg/m2) to those of diabetic sibling pairsdescribed to measure intracellular buffering capacity
[17]. Buffering capacity at each intracellular pH was cal- (Table 1). Type I diabetes duration was, by definition,
longer in the probands than in their respective siblingsculated from (a) the equilibrium between NH41, NH3,
and pH in the extracellular medium, as determined by (Table 1). HbA1c over five years and daily insulin dose
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Table 1. Demographic, clinical and biochemical features for the 17 type I diabetic sibling pairs
Regression r values ANOVA F values
Probands Siblings P values P values
N (male/female) 17 (9/8) 17 (8/9)
Age years 38610 3967 0.75 6.06
0.001 0.0003
Duration of diabetes years 24612 1768 0.88 4.19
0.001 0.003
BMI kg/m2 25.162.9 25.2 62.8 0.29 2.24
0.27 0.054
Hemoglobin A1c % 8.360.8 8.661.4 0.026 1.09
0.92 0.43
Insulin dose U/day 42619 43616 0.155 1.44
0.55 0.23
Mean blood pressure mm Hg 90.169.4 84.3 67.9 0.154 1.12
0.56 0.41
Albumin excretion rate lg/min 6.8 4.9 0.654 4.350
(1–860) (1.8–1334) 0.006 0.003
Creatinine clearance ml/min /1.73 m2 103624 103625 0.321 2.07
0.21 0.074
Data are given as mean 6 sd, except the albumin excretion rate which is given as median and range.
were similar (P values of 0.580 and 0.869, respectively)
in probands and siblings (Table 1). There was no effect
of sibship on these parameters by regression analysis or
analysis of variance. Five probands and two siblings had
AER values exceeding 20 mg/min. Two probands and
two siblings were proteinuric (AER more than 200 mg/
min), whereas three probands had microalbuminuria
(AER between 20 and 200 mg/min). HbA1c values over
five years were significantly higher in diabetic patients
with abnormal (9.30 6 1.03%) versus normal AER
(8.11 6 0.9%, P 5 0.005). AER was similar in probands
and siblings, and there was a correlation (r 5 10.65)
between values in probands and siblings. Analysis of
variance confirmed a significant concordance in AER
Fig. 1. Initial rate of amiloride-sensitive H1 efflux in the recovery from
values (P 5 0.003) between sibling pairs (Table 1). Mean an intracellular acid loading across a wide intracellular pH range in
cultured fibroblasts from type I diabetic sibling pairs and normal controlblood pressure was slightly but not significantly higher
subjects. Cells were acid loaded as described in the Methods section.in probands than in siblings. Three probands were hyper-
Symbols are: ( ) probands; (h) siblings; (j) normal subjects. Each
tensive, and two were on antihypertensive treatment. bar represents the mean 6 sd.
There was no effect of sibship on blood pressure or CCr.
Sodium-hydrogen antiporter activity
Resting intracellular pH (7.3 6 0.04), intracellularCell pH activation for the Na1/H1 exchange, that is,
buffering (26 6 2.81 mmol/liter per pH unit) and thethe initial rates of amiloride-sensitive hydrogen efflux in
kinetic parameters of Na1/H1 exchange (Vmax, 32.5 6cultured fibroblasts in the recovery from intracellular acid
12.5; pH0.5, 6.4 6 0.2; and Hill coefficient, 2.2 6 0.4) wereloading, across a wide pH range was similar at all intracel-
not significantly different in fibroblasts derived from con-lular pH tested between probands and siblings and was
trol as compared with diabetic subjects.similar to those of normal control subjects (Fig. 1).
Vmax, intracellular pH, and buffering capacity were sig-Resting intracellular pH and intracellular buffering
nificantly correlated in the sibling pairs, as confirmed bycapacity in fibroblasts from probands was superimpos-
analysis of variance (Table 2). pH0.5 and Hill coefficient,able on that of cells from their respective siblings (Table
on the contrary, were not concordant between probands2). The kinetic parameters obtained from cell pH activa-
and siblings (Table 2).tion curves for the Na1/H1 exchange, Vmax, pH0.5, and Hill
Vmax was significantly related with only AER (r 5coefficient were similar in probands and siblings (Table
10.49, P 5 0.005) and HbA1c (r 5 10.41, P 5 0.017) in2). Figure 2 shows the individual values of Vmax in pro-
bands and their respective siblings. the total cohort of type 1 diabetic sibling pairs, but not
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Table 2. Intercellular pH, buffering capacity and kinetic parameters of sodium-hydrogen exchange of
cultured fibroblasts from type I diabetic sibling pairs
Regression r values ANOVA F values
Probands Siblings P values P values
Intracellular pH 7.4 60.03 7.3 60.03 0.51 3.26
0.04 0.01
Buffering capacity at resting pH mmol /liter per pH unit 26.062.10 24.6 62.2 0.53 3.36
0.03 0.009
Vmax mmol /min 39.2614.7 40.3 617.6 0.84 11.62
0.0001 0.0001
pH0.5 6.460.14 6.4 60.22 0.35 1.94
0.17 0.09
Hill coefficient 2.3 60.3 2.360.4 0.08 0.86
0.75 0.62
Data are given as mean 6 sd.
in Vmax, intracellular pH, and buffering capacity of the
Na1/H1 exchanger in long-term cultured skin fibroblasts
from type I diabetic sibling pairs. This observation com-
plements previous reports of concordance of sodium-
lithium countertransport activity in identical twins dis-
cordant for type 1 diabetes [19] and suggests that these
in vitro phenotypic characteristics are likely to be, at
least in part, genetically determined. Because diabetic
nephropathy risk has a strong familial component [3, 4]
and because the siblings reported here are also concor-
dant for diabetic nephropathy lesions [20], it is reason-
able to hypothesize that cellular processes are geneticallyFig. 2. Individuals values of Vmax of the sodium-hydrogen antiport in
type I diabetic sibling pairs. The 17 pairs were ranked by the mean regulated. Although the number of patients in this study
value of the two siblings in the pair (indicated by an horizontal line) was small, it is of note that the Na1/H1 exchanger activity
of the Vmax of the sodium-hydrogen antiport. Symbols are: (d) probands; of patients with increased AER was greater than that(s) siblings.
of the normoalbuminuric type I diabetic patients, this
confirming the association of this cellular phenotype with
the presence of renal disease in diabetes [7–12]. Interest-with other clinical variables. However, by multiple re-
ingly, Na1/H1 exchanger activity also tended to be in-gression analysis, using Vmax as the dependent variable,
creased in the normoalbuminuric siblings of patients withthere were no significant correlations between subjects’
increased AER. This argues that higher levels of Na1/age, duration of diabetes, body mass index (BMI), mean
H1 exchanger activity are probably independent of earlyblood pressure, insulin dose, CCr, AER, and mean HbA1c.
renal functional abnormalities.The seven type I diabetic patients with abnormal AER
Hyperglycemia per se is unlikely to explain the concor-(5 probands and 2 siblings) had higher Vmax (54.8 6 3.8
dance in Na1/H1 exchanger activity between diabetic sib-mmol/min) than the 27 patients with normal AER
(35.7 6 15.5 mmol/min, P , 0.005). The normal AER ling pairs. Although univariate analysis showed a signifi-
patients’ Vmax values were similar to those of controls cant relationship between Vmax and HbA1c in the group
(32.5 6 12.5 mmol/min, P 5 0.533). Vmax in the five of diabetic patients as a whole, there was no significant
probands with abnormal AER was similar to that of concordance in HbA1c between sibling pairs, who, on the
their respective siblings (55.17 6 4.57 vs. 60.45 6 7.53 other hand, were highly concordant for Vmax of the anti-
mmol/min), although only two of these siblings had AER port. Furthermore, there was virtually identical transport
exceeding 20 mg/min. Therefore, Vmax in these five sibling activity in patients with normal AER and matched con-
pairs, with at least one member of the pair with abnormal trols, suggesting that hyperglycemia per se does not affect
AER, was higher (57.81 6 6.49 mmol/min) than that in these antiport activities. Because Na1/H1 exchanger ac-
the remaining 12 pairs (32.25 6 12.16 mmol/min, tivity in the siblings was better predicted by the activity
P , 0.0001). in the respective probands than by any other variable,
these findings strengthen the hypothesis that Na1/H1 ex-
DISCUSSION changer activity is mainly genetically regulated.
Although increased Na1/H1 exchanger activity mayThis study demonstrates for the first time, to our
knowledge, that there is a strong familial concordance underlie a predisposition to essential hypertension [21],
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it is unlikely that high blood pressure levels could ac- ide did not prevent the increased incorporation of 3H-
thymidine into DNA in cells from type I diabetic patientscount for our findings, in that no correlation was found
between mean blood pressure in their sibling pairs. The with nephropathy [11].
cause for the concordance in Na1/H1 exchanger activity Although the connection between enhanced sodium-
was not investigated in this study. Most of the sodium- hydrogen antiport activity and diabetic nephropathy re-
dependent H1 efflux in fibroblasts is probably attribut- mains unknown, these data support the view that the
able to NHE-1 [22], the isoform ubiquitously expressed increased susceptibility to diabetic nephropathy resides
in all mammalian cells. The concordance observed in in the host cell response to diabetes-induced metabolic
type I diabetic sibling pairs could be due to the common derangement and is genetically determined. Whether de-
presence of different alleles of the NHE-1 gene in the termination of Na1/H1 antiport activity will become a
sibling pairs or to similar levels of NHE-1 gene expres- useful marker to identify patients at risk of developing
sion [23]. Regarding the latter hypothesis, preliminary diabetic renal disease will require longitudinal studies.
studies indicate increased mRNA levels for the NHE-1
gene in cultured skin fibroblasts of type I diabetic pa- ACKNOWLEDGMENTS
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